Yellow fever vaccination for immunocompromised travellers: unjustified vaccination hesitancy?

Improved quality of life in immunocompromised patients opens travel opportunities, but administering the yellow fever (YF) vaccine is often contraindicated. We advocate re-evaluating this position for immunocompromised patients who travel frequently or who are migrating to regions in which YF is end...

Descripción completa

Detalles Bibliográficos
Autores principales: de Jong, Wesley, de Man, Rob A, Dalm, Virgil A S H, Reusken, Chantal B E M, Goeijenbier, Marco, van Gorp, Eric C M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6735878/
https://www.ncbi.nlm.nih.gov/pubmed/30850844
http://dx.doi.org/10.1093/jtm/taz015
Descripción
Sumario:Improved quality of life in immunocompromised patients opens travel opportunities, but administering the yellow fever (YF) vaccine is often contraindicated. We advocate re-evaluating this position for immunocompromised patients who travel frequently or who are migrating to regions in which YF is endemic.

Ejemplares similares